GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adcock Ingram Holdings Ltd (JSE:AIP) » Definitions » ROC (Joel Greenblatt) %

Adcock Ingram Holdings (JSE:AIP) ROC (Joel Greenblatt) % : 29.01% (As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Adcock Ingram Holdings ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Adcock Ingram Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 29.01%.

The historical rank and industry rank for Adcock Ingram Holdings's ROC (Joel Greenblatt) % or its related term are showing as below:

JSE:AIP' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 19.43   Med: 32.5   Max: 36.19
Current: 31.52

During the past 13 years, Adcock Ingram Holdings's highest ROC (Joel Greenblatt) % was 36.19%. The lowest was 19.43%. And the median was 32.50%.

JSE:AIP's ROC (Joel Greenblatt) % is ranked better than
78.63% of 1048 companies
in the Drug Manufacturers industry
Industry Median: 8.41 vs JSE:AIP: 31.52

Adcock Ingram Holdings's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -0.70% per year.


Adcock Ingram Holdings ROC (Joel Greenblatt) % Historical Data

The historical data trend for Adcock Ingram Holdings's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adcock Ingram Holdings ROC (Joel Greenblatt) % Chart

Adcock Ingram Holdings Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.76 29.02 33.27 34.94 32.23

Adcock Ingram Holdings Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.25 35.23 30.98 33.36 29.01

Competitive Comparison of Adcock Ingram Holdings's ROC (Joel Greenblatt) %

For the Drug Manufacturers - Specialty & Generic subindustry, Adcock Ingram Holdings's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adcock Ingram Holdings's ROC (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adcock Ingram Holdings's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Adcock Ingram Holdings's ROC (Joel Greenblatt) % falls into.



Adcock Ingram Holdings ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2179.249 + 2404.537 + 0) - (2119.264 + 0 + 104.971)
=2359.551

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1944.035 + 2541.001 + 206.652) - (1390.584 + 0 + 1097.304)
=2203.8

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Adcock Ingram Holdings for the quarter that ended in Jun. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1144.812/( ( (1689.321 + max(2359.551, 0)) + (1639.03 + max(2203.8, 0)) )/ 2 )
=1144.812/( ( 4048.872 + 3842.83 )/ 2 )
=1144.812/3945.851
=29.01 %

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adcock Ingram Holdings  (JSE:AIP) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Adcock Ingram Holdings ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Adcock Ingram Holdings's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Adcock Ingram Holdings Business Description

Traded in Other Exchanges
N/A
Address
1 New Road, (c/o New Road & 7th Street), Midrand, Johannesburg, GT, ZAF, 1682
Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company generates roughly two-thirds of its sales from the private sector, with the remaining from the public sector. Adcock operates in four broad areas: renal disease, medicine delivery, transfusion therapies, and blood and specialized pharmaceuticals. The company generates the vast majority of its revenue in southern Africa, followed by the rest of Africa and India.